BioCentury
ARTICLE | Financial News

Cel-Sci completes direct public offering

May 30, 2016 7:00 AM UTC

Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va. Business: Cancer, Infectious Date completed: 2016-05-24 Type: Direct public offering Raised: $5 million Shares: 10 million Price: $0.50 Shares after offering: 1...